Anonymous
Guest
Anonymous
Guest
From financial news article published last week:
"Two other companies that Pfizer could have acquired -*Actavis*andAstraZeneca*- are "off the table," the analyst stated. Actavis has agreed to acquire Allergan*, which makes a purchase of Actavis unlikely.*"
Thoughts?
"Two other companies that Pfizer could have acquired -*Actavis*andAstraZeneca*- are "off the table," the analyst stated. Actavis has agreed to acquire Allergan*, which makes a purchase of Actavis unlikely.*"
Thoughts?